Page last updated: 2024-12-07
eutypine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
eutypine: isolated from Eutypa lata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 129326 |
| CHEMBL ID | 501128 |
| SCHEMBL ID | 272100 |
| MeSH ID | M0267680 |
Synonyms (11)
| Synonym |
|---|
| C08448 , |
| 4-hydroxy-3-(3-methyl-3-butene-1-ynyl)benzaldehyde |
| eutypine |
| 121007-17-8 |
| CHEMBL501128 , |
| AC1L2VEO , |
| 4-hydroxy-3-(3-methylbut-3-en-1-ynyl)benzaldehyde |
| SCHEMBL272100 |
| DTXSID60153107 |
| 4-hydroxy-3-(3-methyl-3-butene-1-ynyl) benzaldehyde |
| benzaldehyde, 4-hydroxy-3-(3-methyl-3-buten-1-ynyl)- |
Research Excerpts
Overview
Eutypine is a toxin produced by Eutypa lata, the causal agent of the dying-arm disease of grapevine.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Eutypine is a toxin produced by Eutypa lata, the causal agent of the dying-arm disease of grapevine. " | ( Protonophoric activity of eutypine, a toxin from Eutypa lata, in plant mitochondria. Davy de Virville, J; Deswarte, C; Eychenne, J; Fallot, J; Moreau, F; Roustan, JP, 1996) | 2.04 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID334213 | Phytotoxicity against grape leaf by leaf disk assay | 2003 | Journal of natural products, Feb, Volume: 66, Issue:2 | Synthesis and structure-phytotoxicity relationships of acetylenic phenols and chromene metabolites, and their analogues, from the grapevine pathogen Eutypa lata. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.42
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.42) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||